Moderna COVID-19 Booster with Shingles or Influenza Vaccine Study
Moderna COVID-19 Booster Along with the Shingles or Influenza Vaccine Trials in Columbus
Aventiv Research is currently participating in an investigational COVID-19 booster along with the shingles or influenza vaccine study at our Columbus, Ohio location.
Moderna COVID-19 Booster Along with the Shingles or Influenza Vaccine Study
The purpose of this research study is to test how an extra third dose of a Covid-19 vaccine works when given at the same time as a vaccine against shingles (herpes zoster) OR a vaccine against seasonal flu (influenza). The Covid-19 vaccine you will receive in this study is ModernaTX, Inc’s mRNA-1273. You must have already received 2 doses of this vaccine, six months prior, to be able to join this study.
We are specifically looking for volunteers who are:
- Healthy adults aged 50 years or older to participate in the Shingles and mRNA-1273 booster cohort
- Participants will receive 2 doses of a shingles study vaccine and a third dose of Moderna’s Covid-19 study vaccine (a booster dose).
- Healthy adults aged 18 years or older to participate in the Influenza and mRNA-1273 booster cohort
- Participants will receive the seasonal flu study vaccine and a third dose of Moderna’s Covid-19 study vaccine (a booster dose).
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for our COVID-19 booster with shingles or influenza vaccine clinical research study. Qualified volunteers may be compensated for time and travel.